An Observational Study of Xeloda (Capecitabine) Monotherapy in Patients With Colorectal Cancer (AXEL)
Clinical trial NCT01276405 · TERMINATED
Trial details
- NCT number
- NCT01276405
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2010-03-01
- Primary completion
- 2015-10-01
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.